These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23842141)

  • 1. Does high-density lipoprotein influence the development of saphenous vein graft disease after coronary bypass surgery?: exploratory analysis from the CASCADE trial.
    Jerzewski K; Ruel M; Voisine P; Le May MR; Kulik A
    J Cardiothorac Surg; 2013 Jul; 8():172. PubMed ID: 23842141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial.
    Kulik A; Voisine P; Mathieu P; Masters RG; Mesana TG; Le May MR; Ruel M
    Ann Thorac Surg; 2011 Oct; 92(4):1284-90; discussion 1290-1. PubMed ID: 21958773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial.
    Une D; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2013 Sep; 128(11 Suppl 1):S213-8. PubMed ID: 24030409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial.
    Kulik A; Le May MR; Voisine P; Tardif JC; Delarochelliere R; Naidoo S; Wells GA; Mesana TG; Ruel M
    Circulation; 2010 Dec; 122(25):2680-7. PubMed ID: 21135365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.
    Hess CN; Lopes RD; Gibson CM; Hager R; Wojdyla DM; Englum BR; Mack MJ; Califf RM; Kouchoukos NT; Peterson ED; Alexander JH
    Circulation; 2014 Oct; 130(17):1445-51. PubMed ID: 25261549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial.
    Taggart DP; Webb CM; Desouza A; Yadav R; Channon KM; De Robertis F; Di Mario C
    J Cardiothorac Surg; 2018 Nov; 13(1):117. PubMed ID: 30453984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial.
    Goldstein DJ; Chang HL; Mack MJ; Voisine P; Gammie JS; Marks ME; Iribarne A; Vengrenyuk Y; Raymond S; Taylor BS; Dagenais F; Ailawadi G; Chu MWA; DiMaio JM; Narula J; Moquete EG; O'Sullivan K; Williams JB; Crestanello JA; Scavo V; Puskas JD; Acker MA; Gillinov M; Gelijns AC; O'Gara PT; Moskowitz AJ; Alexander JH; Bagiella E
    J Thorac Cardiovasc Surg; 2024 May; 167(5):1782-1792.e5. PubMed ID: 36494209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.
    Gluckman TJ; McLean RC; Schulman SP; Kickler TS; Shapiro EP; Conte JV; McNicholas KW; Segal JB; Rade JJ
    J Am Coll Cardiol; 2011 Mar; 57(9):1069-77. PubMed ID: 21349398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting.
    Taggart DP; Ben Gal Y; Lees B; Patel N; Webb C; Rehman SM; Desouza A; Yadav R; De Robertis F; Dalby M; Banning A; Channon KM; Di Mario C; Orion E
    Ann Thorac Surg; 2015 Jun; 99(6):2039-45. PubMed ID: 25886810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saphenous vein graft disease: review of pathophysiology, prevention, and treatment.
    Kim FY; Marhefka G; Ruggiero NJ; Adams S; Whellan DJ
    Cardiol Rev; 2013; 21(2):101-9. PubMed ID: 22968180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of preexisting pathology in the development of neointimal hyperplasia in coronary artery bypass grafts.
    Kon ZN; White C; Kwon MH; Judy J; Brown EN; Gu J; Burris NS; Laird PC; Brown T; Brazio PS; Gammie J; Brown J; Griffith BP; Poston RS
    J Surg Res; 2007 Oct; 142(2):351-6. PubMed ID: 17631906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter by Gasparovic et al regarding article, "Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial".
    Gasparovic H; Petricevic M; Biocina B
    Circulation; 2011 Aug; 124(6):e193; author reply e195-6. PubMed ID: 21824930
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the optimal management for preventing saphenous vein graft diseases?: early results of intravascular angioscopic assessment.
    Hata M; Sezai A; Niino T; Yoda M; Wakui S; Chiku M; Takayama T; Honye J; Saitoh S; Minami K
    Circ J; 2007 Feb; 71(2):286-7. PubMed ID: 17251683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter by Bisdas et al regarding article, "Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial".
    Bisdas T; Haverich A; Teebken OE
    Circulation; 2011 Aug; 124(6):e194; author reply e195-6. PubMed ID: 21824931
    [No Abstract]   [Full Text] [Related]  

  • 16. External Stents for Vein Grafts in Coronary Artery Bypass Grafting: Targeting Intimal Hyperplasia.
    Weltert LP; Wolf LG; Garufi L; Scaffa R; Salica A; Ricci A; Irace FG; Fusca S; D'Aleo S; Chirichilli I; Bellisario A; de Paulis R
    Surg Technol Int; 2020 May; 35():197-201. PubMed ID: 32120449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the size mismatch between saphenous vein graft and coronary artery on graft patency.
    Yamane Y; Uchida N; Okubo S; Morimoto H; Mukai S
    Gen Thorac Cardiovasc Surg; 2017 Jan; 65(1):25-31. PubMed ID: 27485249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasia.
    Meirson T; Orion E; Di Mario C; Webb C; Patel N; Channon KM; Ben Gal Y; Taggart DP
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):871-8. PubMed ID: 26242834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events randomized clinical trial.
    Kulik A; Abreu AM; Boronat V; Ruel M
    J Thorac Cardiovasc Surg; 2019 Jan; 157(1):151-161.e1. PubMed ID: 30122341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.